Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting long-chain acylcarnitine accumulation to protect cardiac mitochondrial homeostasis after complete revascularization. | Cell Rep Med | 2025 | 41406945 | PubTator, text mining | PubMed |
| Deciphering the structural impact of norepinephrine analog radiopharmaceuticals on organic cation transporter affinity. | Biomed Pharmacother | 2025 | 41172956 | PubTator, text mining | PubMed |
Putative new biomarkers for renal transporter-mediated drug-drug interactions: Characterization as substrates of organic cation transporter 2, multidrug and toxin extrusion protein 1, and other important drug transporters. | Drug Metab Dispos | 2025 | 41072274 | PubTator, text mining | PubMed |
| Pharmacogenetics and Molecular Ancestry of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Ecuadorian Subjects with Type 2 Diabetes Mellitus. | Pharmaceuticals (Basel) | 2025 | 41011206 | PubTator, text mining | PubMed |
| Phytochemicals Daturilinol and Withametelin B identified as novel Bcl2 inhibitors via virtual screening and molecular simulations. | Sci Rep | 2025 | 41006810 | PubTator, text mining | PubMed |
| Critical Review of Hearing Rehabilitation in Pediatric Oncology: Specific Considerations and Barriers. | Curr Oncol | 2025 | 41002579 | PubTator, text mining | PubMed |
| Diversity of human choline transporters: substrate specificity, kinetic properties, and inhibitor sensitivity. | Biochem Pharmacol | 2025 | 40972734 | Swiss-Prot, curated | PubMed |
| Prognostic associations of PFAS in ovarian cancer: Insights from exploratory analysis. | Ecotoxicol Environ Saf | 2025 | 40945090 | PubTator, text mining | PubMed |
| Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity. | Nat Commun | 2025 | 40885711 | PubTator, text mining | PubMed |
| Persistent Inflammation, Maladaptive Remodeling, and Fibrosis in the Kidney Following Long COVID-like MHV-1 Mouse Model. | Diseases | 2025 | 40863220 | PubTator, text mining | PubMed |
| Efficacy and safety of B/F/TAF in treatment-naïve and virologically suppressed people with HIV ≥ 50 years of age: integrated analysis from six phase 3 clinical trials. | BMC Infect Dis | 2025 | 40846915 | PubTator, text mining | PubMed |
| Dolutegravir + lamivudine effectiveness and tolerability in real-world cohorts with HIV-1 across Asia and South America: A systematic literature review. | Medicine (Baltimore) | 2025 | 40826695 | PubTator, text mining | PubMed |
| Transport of Small Aliphatic Amines by Polyspecific Solute Carriers: Deciphering Structure-Function Relationships. | ACS Pharmacol Transl Sci | 2025 | 40810150 | PubTator, text mining | PubMed |
| Post-marketing safety concerns with dolutegravir: a pharmacovigilance study based on the FDA adverse event reporting system database. | Front Pharmacol | 2025 | 40808681 | PubTator, text mining | PubMed |
| Influence of OCT2 gene variants on metformin efficacy in type 2 diabetes: insights into pharmacogenomics and drug interactions. | J Transl Med | 2025 | 40775340 | PubTator, text mining | PubMed |
| Assessment of drug permeability using a small airway microphysiological system. | Front Pharmacol | 2025 | 40746730 | PubTator, text mining | PubMed |
| Protective Effect of Palonosetron against Cisplatin-Induced Cytotoxicity via Decreased Phosphorylation of p38. | Biol Pharm Bull | 2025 | 40738650 | PubTator, text mining | PubMed |
| In vitro transporter substrate properties of previously reported biomarkers for renal OAT1/OAT3-mediated drug-drug interactions. | Biochem Pharmacol | 2025 | 40692107 | PubTator, text mining | PubMed |
| EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients. | PLoS One | 2025 | 40526606 | PubTator, text mining | PubMed |
| Genetic polymorphism contributes to efficacy and adverse reactions of tenofovir combination lamivudine-based highly active antiretroviral therapy in HIV-infected patients. | Hum Immunol | 2025 | 40466234 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=3